Immatics N.V.: Trading Below Cash, But Not Without Reason
Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...
BestReviews on MSN22h
The best deals of Amazon's Big Spring Sale
Sale Spring is here, and Amazon is dropping deals on everything from water bottles and dresses to self-care items and outdoor ...